Background. Dengue is the most common mosquito-borne viral disease in humans. With this study, we aimed to investigate the risk of vertical (DENV) transmission during the peripartum period and to describe its viral kinetics in serum and breast milk.
INTRODUCTION
Every year, dengue virus (DENV) causes approximately 390 million infections, 500 000 hospitalizations, and 12 500 deaths in tropical and subtropical regions [1, 2] . Infection with 1 of the 4 serotypes of this Flavivirus does not provide long-term cross-protective immunity against the other 3 serotypes [3, 4] , and infection causes a large spectrum of clinical manifestations, from asymptomatic infection or mild dengue fever to severe and potentially lethal disease [2] . There is no available antiviral treatment, and research on vaccines continues; only 1 dengue vaccine has been licensed. Current vector-control measures are seldom sufficient to prevent epidemics.
The major mode of human DENV infection is through mosquito bites. However, other transmission modes, such as through the blood, transplant [5] , mucocutaneous [6] , and maternal-fetal routes [7] , have been described. The occurrence of dengue infection during pregnancy is uncommon, but mother-fetus transmissions, with severe consequences for mothers and their newborns (ie, prematurity, fetal death, low birth weight, acute fetal distress, and hemorrhage), have been reported in the literature [5, [7] [8] [9] [10] . Vertical (mother-to-child) transmission of arboviruses with alphaviruses such as Chikungunya virus [11, 12] and with flaviviruses such as DENV [7, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] has been reported in some cases reports or small series of West Nile virus [23, 24] , yellow fever virus [25] , and, more recently, Zika virus [26] . Furthermore, arbovirus transmission through breast milk has already been reported with West Nile virus [23] , vaccine strains of yellow fever virus [27, 28] , Zika virus [29] , and DENV [13] . We previously isolated infectious viral particles of DENV-1 from breast milk and reported a possible case of vertical transmission through breastfeeding [13] . To date, there have been no recommendations for preventing DENV transmission and maternofetal complications during pregnancy, delivery, or breastfeeding.
We conducted a prospective study during the largest outbreak of dengue infection recorded in New Caledonia (2012-2013) [30] . The purpose of this study was to investigate the risk of vertical DENV transmission during the peripartum period (transmission rate and mechanisms) and to describe viral kinetics in maternal and neonatal sera and in breast milk.
MATERIAL AND METHODS

Study Design
This study took place from December 2012 to October 2013 at the maternity ward in Centre Hospitalier Territorial (CHT) in Nouméa, New Caledonia, during a dengue outbreak. All parturient women who developed fever between 7 days before and 2 days after delivery were investigated to determine the etiology of their fever; testing included a complete blood count, blood culture, urine cytobacteriology, and measurement of C-reactive protein and transaminase levels. In the context of a dengue epidemic and when clinical signs were compatible with dengue infection, laboratory confirmation was requested.
Only DENV-positive parturient women and their newborns were included in this study. We used medical records and interviewed the patients to collect clinical and biological data. For mothers, data regarding the main characteristics of their gestational period, time and mode of delivery, clinical signs, symptoms, platelet count, and treatment were extracted from the database. For newborns, the data collected included Apgar score, birth weight, sex, feeding mode (artificial and/or breastfeeding), clinical signs, platelet count, and treatment. Samples were collected sequentially from mothers (sera and breast milk) and their newborns (sera). Umbilical cord blood, gastric liquid (newborns), and placentas were collected at the time of delivery, as a routine procedure for febrile mothers. Additional breast milk samples were obtained from nonhospitalized breastfeeding mothers who had developed dengue infection during the postpartum period. Parturient women and breastfeeding mothers were detected through hospital practitioner surveillance and by health authorities through the arboviruses sentinel network.
Laboratory Diagnosis
Laboratory confirmation of dengue infection was performed by using quantitative reverse-transcription polymerase chain reaction (qRT-PCR) [31] and serotype-specific DENV primers [32] . DENV RNA concentrations were quantified using a standard curve generated from dilutions of a stock DENV-quantified RNA preparation. Serological dengue infection status was assessed on sera by using distinct anti-DENV immunoglobulin M (IgM) and IgG tests (dengue IgM/IgG capture enzymelinked immunosorbent assay [Panbio Diagnostics, Brisbane, Australia]).
Viral Isolation
Viral strains were isolated from DENV-1-positive samples. Samples were inoculated on monolayer C6/36 Aedes albopictus cells and incubated at 28°C in Leibovitz 15 medium (Sigma, St Louis) with 2% fetal bovine serum (Gibco, Life Technologies, Auckland, New Zealand), 1% penicillin-streptomycin (Gibco, Life Technologies, Auckland, New Zealand), 1% amphotericin B (Eurobio, Les Ulis, France), and 10% tryptose phosphate broth (Gibco, Life Technologies, Auckland, New Zealand). Cell culture supernatants were harvested 5 days later and passed again twice. Plates were fixed with 3.6% formaldehyde and analyzed with an indirect immunofluorescence assay with a monoclonal mouse anti-dengue complex (2H2) and Alexa Fluor-conjugated goat anti-mouse IgG (Molecular Probes, Life Technologies, Oregon) to detect infectious viral particles.
Phylogenetic Analyses
Total viral RNA was extracted from sera or cell supernatants using a total nucleic acid isolation kit (Roche Diagnostics, Auckland, New Zealand). DENV-1 envelope gene sequences were amplified using RT-PCR and generated as described previously [30] . Phylogenetic analysis then was performed using a maximum-likelihood method with MEGA 5.0 software. The evolutionary distances were computed using the Kimura 2-parameter method.
Statistical Analysis
The severity and duration of thrombocytopenia were compared between mothers and newborns using a Mann-Whitney U test. Correlation analyses (using the Pearson coefficient) between the nadir and duration of thrombocytopenia among mothers and newborns were performed. Statistical analyses were performed using the R 3.1.3 software package (R Development Core Team), and p values of <.05 indicate statistical significance.
Ethics Statement
Ethical approval was granted by the People Protection Committee South-West and Overseas III (Bordeaux, France). All parturient women were informed about the study proceedings, and their consent was obtained.
RESULTS
Obstetric Complications
During this 11-month study, 10 symptomatic parturient women were diagnosed with dengue infection (9 primary infections and 1 secondary infection) between 7 days before and 2 days after delivery (Supplementary Table 1 ) at the CHT (the largest maternity ward in New Caledonia). This group represents 0.924‰ (10 of 10 813) of the cases of dengue infection diagnosed in New Caledonia during the study period and 2.5‰ (10 of 4098) of all parturient women in New Caledonia during the same period.
Clinical signs occurred before delivery in 4 cases, the day of delivery in 5 cases, and 2 days after delivery in 1 case. Only 1 woman (in pair 3) had an anteriority of dengue infection (Supplementary Table 1 ). Three women with dengue infection had no warning signs, 4 had warning signs, and 3 had severe dengue disease according to the World Health Organization case classification of dengue infection [2] . Symptoms that lasted for 1 to 7 days (average, 3.2 days) included fever (10 cases), arthromyalgia (4 cases), headache (2 cases), itchiness (2 cases), and skin eruption (1 case). Concomitant to dengue infection, 1 mother (in pair 4) had a urinary tract infection, and 1 (in pair 7) had an Escherichia coli K1 vaginal colonization (Supplementary Table 1 ). Eight mothers developed thrombocytopenia (platelet count, <150 G/L; platelet nadir, 11-140 G/L; duration, 1-7 days [mean, 3.6 days]), 1 of whom (in pair 10) required platelet transfusions (Supplementary Table 1 ; Figure 1 ). The patients delivered their infant between 36 and 40 weeks of amenorrhea (mean, 38 weeks). One preterm birth (10%) was recorded, which is consistent with the local rate. Three (30%) emergent cesarean deliveries were performed; the usual local rate is 20%. Three (30%) hemorrhagic complications occurred between 5 hours before and 7 days after delivery (Supplementary Table 1 ); a 2.5% rate of hemorrhagic complications during delivery is usually observed. One (10%) death occurred; the regional mortality rate is 8.4 per 100 000 live births. The mother who died (in pair 10) presented with dengue infection with warning signs concomitant with gestational hypertension. After cesarean delivery while she was severely thrombocytopenic, she presented severe dengue infection with hemorrhage, disseminated intravascular coagulation, and multiple organ failure without plasma leakage.
Neonatal Complications
Nine (90%) of 10 newborns were infected with DENV-1, all 9 were symptomatic. The disease started from the day of birth to 7 days of life (mean onset, 4 days of life). The illness lasted from 1 to 10 days (mean duration, 7 days). The delay between the mother's and her newborn's disease onset ranged from 0 to 8 days (mean delay, 4.6 days). Among the newborns with dengue infection, 1 (in pair 1) had no warning signs, and 8 had warning signs. Symptoms included fever (8 cases), hypoxemia (4 cases), moaning (3 cases), feeding difficulties (3 cases), hypotonia (2 cases), skin eruption (1 case), and skin blotches (1 case). Eight newborns required hospitalization in the neonatology department. As a result of delivery difficulties, 2 newborns required mechanical ventilation, and 2 others required resuscitation at birth that in 1 case (in pair 10) led to anoxic encephalopathy without sequelae 12 months later (Supplementary Table 1 
Evaluation of Vertical DENV Transmission in the Studied Population
Results of DENV qRT-PCR samples collected from mothers and their newborns are presented in Table 1 . qRT-PCR results were positive in all the mothers and 9 of the newborns, which indicates a 90% DENV-transmission rate. DENV qRT-PCR results were positive for 5 of 6 breast milk samples, 3 of 3 placentas, 3 of 4 cord blood samples, and 4 of 7 gastric fluid samples. Samples collected on a routine basis (particularly from placentas) were not always available. Six additional breast milk samples were obtained from 25 nonhospitalized breastfeeding mothers who had developed dengue infection during their postpartum period, and qRT-PCR results were positive in 4 of these mothers. In breast milk samples obtained from 12 mothers, 9 (75%) tested positive. The 3 breast milk with a negative qRT-PCR result corresponded to samples collected later (8-21 days after the mother's disease onset).
All scenarios of vertical DENV transmission are presented in Supplementary Table 1 and Table 1 . It should be noted that the only newborn who was uninfected (in pair 4) was born from a mother who had presented a classic form of primary dengue infection (no bleeding and no thrombocytopenia) along with a urinary tract infection 4 days before spontaneous vaginal delivery. The corresponding placenta and cord blood were not tested, but gastric fluid and breast milk samples tested negative. In pair 1, the chronology of dengue infection suggests possible transmission through breastfeeding (see Supplementary  Figure) . Indeed, the mother was viremic the day of delivery (spontaneous vaginal delivery) and became ill on day 2, and her newborn, breastfed during his first 6 days of life, was viremic on day 4 and developed symptoms of dengue infection on day 7. DENV-1 qRT-PCR results for a cord blood sample were negative and for a breast milk sample were positive. However, results of placenta and gastric fluid analyses were not available.
To evaluate the potential infectivity of breast milk, cell cultures of qRT-PCR samples (sera and breast milk) that had tested positive were performed. All breast milk culture results remained negative, and only 5 serum samples (from pairs 6, 7, and 8) tested positive in an indirect immunofluorescence assay or qRT-PCR screening.
Partial E gene sequences were obtained from positive supernatants or directly from positive sera. The 6 DENV-1 sequences generated in this study belong to DENV-1/genotype I SouthEast Asia and cluster with other DENV-1 sequences strains collected during the same epidemic period in New Caledonia (Figure 2 ). Among pairs 2, 7, and 8, the sequences obtained from the mothers' and newborns' sera were 100% identical, which is consistent with vertical transmission of DENV. Between these 3 mother-newborn pairs, the percentage of homology ranged from 99.5% to 99.8%, which is similar to the percentages of homology observed with the other DENV-1 strains isolated during the same period, as previously observed for DENV-1 in New Caledonia [13, 30] .
Viral Kinetics in Mother-Newborn Sera and Breast Milk
We studied DENV RNA kinetics in the sera of the 10 parturient women infected during their peripartum period and 9 infected newborns and in breast milk samples collected from 12 breastfeeding mothers (6 of the 10 parturient women studied and 6 mothers infected later during their postpartum period). Maximal DENV RNA loads ranged from 10 4 to 2.5 × 10 8 copies of RNA/mL in mothers' and newborns' sera (Figures 3 and  4 ; see also Supplementary Figure) . The DENV RNA load from the 1 mother who died (in pair 10) was evaluated to be 1.5 × 10 6 copies of RNA/mL; thus, she was less viremic at delivery than the other parturient women. DENV RNA loads were lower in breast milk samples, ranging from 20 to 2.5 × 10 4 copies of RNA/mL (Figure 3) . In breast milk compared to sera, DENV RNA kinetics were characterized by a prolonged detection of DENV after a plateau phase. DENV RNA was detected in breast milk until 14 days after disease onset. DENV RNA kinetics were also prolonged in the newborns' sera until 10 to 17 days ( Figure  4 ; see also Supplementary Figure) .
DISCUSSION
Here we describe the outcome of near-term maternal dengue infections. During the 11 months of the study, other dengue infections might have occurred earlier during some pregnancies (first and second trimester), but this outcome and its consequences on newborns, if any, were not included in our study. We report here a very high mother-to-newborn DENVtransmission rate that reached 90% during the peripartum period. This result was unexpected and considerably higher than the 15% transmission rate reported from a previous retrospective study (French Guyana 1992 -2006 [7] . This result can be explained by differences regarding the study design (prospective vs retrospective) and the dengue diagnosis methods (qRT-PCR vs IgM detection). Several factors might explain the high transmission level observed in our series. First, all parturient women were symptomatic and infected with high viral loads, which may have enhanced the risk of vertical transmission.
Second, it is likely that newborns were not protected by maternal DENV-specific IgG antibodies transmitted through the placenta, because all of their mothers, except 1, had experienced a primary dengue infection. However, the putative protection from maternal DENV antibodies to newborns is unclear [33] [34] [35] . Third, the observed vertical-transmission risk might Figure 2 . Phylogenetic tree based on partial envelope (E) gene sequences of dengue virus 1 (DENV-1). Shown are original maximum-likelihood trees derived from 33 DENV-1 E gene sequences (716 bp) retrieved from GenBank, previously obtained [30] or obtained for this study (in bold). The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown for values higher than 75. The period (years) in which these strains were collected is indicated just after the country's isocode (NC indicates New Caledonia). The GenBank accession numbers of the DENV-1 E gene sequenced for this study are KT698215 through KT698220. In this study, newborn 8 and pair 7 sequences were obtained from supernatant cultures. Sequences from pair 2, mother 8, and other DENVs isolated during the 2013-2014 period were obtained from direct sequencing of sera.
have been influenced by the fitness of the circulating DENV-1 (genotype I) strains. Indeed, this study occurred during a major DENV outbreak caused by this newly introduced genotype and was particularly severe in terms of case numbers, hospitalization rates, and uncommon complications [30] . The results of previous studies suggest that some DENV strains can be characterized by higher viral fitness [36, 37] that may influence the risk of transmission. Considering the consequences of dengue infection, we observed obstetric and neonatal complications similar to those reported in the literature [13] [14] [15] [16] [17] 21] . We found a lower rate of prematurity (10%) than that in the French Guyana studies (21% and 19.6%) [7, 15] . However, we focused on the late peripartum period, whereas in the previous studies, parturient women infected during the whole duration of the pregnancy were included. Maternal hemorrhagic complications and maternal deaths were more frequent in our series than in the previous ones (30% vs 10% and 10% vs 1.9%, respectively) [7] . Although the percentage of hemorrhagic complications in the peripartum period increased in DENV-positive mothers, it is difficult to differentiate consequences linked to dengue infection (thrombocytopenia) from those attributable to a surgical procedure. Furthermore, the same conclusion can be postulated for the death caused by multisystem organ failure. In our study, the occurrence of bleeding was higher in the mothers than in their newborns, although the severity of thrombocytopenia (duration and nadir) was lower in the mothers than in their newborns, but this result was not statistically significant ( Figure 1 ). Newborn complications were frequent and caused by neonatal dengue infection and/or were delivery-related complications.
Our results suggest the importance of prolonged surveillance of infants born from mothers infected by DENV during the peripartum period, particularly those who developed obstetric and/ or hemorrhagic complications. Mechanisms of vertical DENV transmission are difficult to study because the occurrence of dengue infection in the peripartum period is rare, and no good experimental animal model designed to study dengue infection exists. Larger prospective studies based on sequential samples of maternal serum, placenta, cord blood, gastric fluid, and breast milk and newborn serum are required to improve our understanding of motherto-child DENV transmission. In our study, some cases were more suggestive of antenatal or perinatal contamination (pairs 2, 3, 7, and 8), and other cases were more suggestive of postnatal contamination (pairs 1 and 9). In these pairs, DENV RNA was detected in breast milk and sera. For pair 9, no other biological fluids were available, and for pair 1, cord blood (the only additional sample) tested negative. Although pair 1 possibly involved DENV transmission through breastfeeding, contamination through the placenta or during delivery cannot be ruled out. Moreover, viral transmission through the ophthalmologic, buccal, or digestive mucosa seems possible, particularly in newborns who require intensive care favoring mucosal lesions. Nevertheless, this study has provided additional data regarding the risk of breast milk contamination, because DENV RNA detection was frequent and prolonged (until 10 days after disease onset) (Figure 3 ; see also Supplementary Figure) . This DENV RNA detection might correspond to infectious, defective, or deteriorated DENV particles. Because no virus was recovered from a cell culture in this study, it was not possible to confirm the infectivity of the DENV strains found in the breast milk samples, although viral culture results were positive in our previous case report [13] and for other flaviviruses [29] .
We describe here for the first time, to our knowledge, the evolution of DENV kinetics in both maternal and neonatal sera and in breast milk. In breast milk, viral kinetics were characterized by a prolonged presence of DENV RNA after a plateau phase that contrasted with the parabolic curve of viremia, which suggests increased clearance of DENV in breast milk, as described for urine [38, 39] . Viral kinetics observed in neonatal sera provide a reliable example of the natural evolution of viremia after vertical transmission, including the early phase of dengue infection before symptom onset. Newborns had prolonged viremia until 10 to 17 days after disease onset, longer than that in adults (Figure 4 ; see also Supplementary Figure) [40] , which might be explained by the relative immaturity and delayed response of newborns' immune system [5] .
Despite the small scale of our study, our results provide new avenues for preventive measures related to vertical DENV transmission risks in mothers and newborns, including i) early dengue diagnosis using direct tests in febrile and/ or thrombocytopenic parturient women living in countries in which the disease is endemic/epidemic and ii) a close and prolonged surveillance of infected mothers and their newborns, particularly those born from mothers who developed obstetric and/or hemorrhagic complications. The hypothetical protective effects of delaying delivery (after the viremia phase), of administrating preventive platelet transfusion, of avoiding delivery-invasive procedures, and/or of temporary interruption of breastfeeding are not known. This study raises the issue of the balance between unknown breastfeeding risks and the well-known breastfeeding benefits in tropical and subtropical countries in which dengue infection represents a major public health problem and in which most young children are breastfed. Multisite studies using similar methods of investigation are required to improve our understanding of vertical transmission mechanisms and to propose easily implementable preventive recommendations.
